Skip to main content
ESTA
NASDAQ Industrial Applications And Services

Establishment Labs Reports Strong 2025 Growth, Resolves Internal Control Weakness Amidst Insider Selling Plan & Supply Risk

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$78.7
Mkt Cap
$2.287B
52W Low
$26.555
52W High
$83.31
52W Position info
196% above low
Off High info
5.5% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

ESTA has more than doubled off its 52-week low of $26.555.

Summary

Establishment Labs reported strong 2025 financial results with significant revenue growth and reduced net losses, driven by successful US market entry and new product launches, while also resolving a prior material weakness in internal controls. However, the filing also disclosed a significant insider selling plan and a critical supply chain risk with its sole silicone supplier.


Key Events · Earnings and Guidance · ESTA

  • Strong 2025 Financial Performance

    Revenue increased by 27.2% to $211.1 million, and net loss was significantly reduced to $51.1 million for the year ended December 31, 2025. Gross margin improved to 69.3%.

  • Successful U.S. Market Entry

    Following FDA approval in September 2024, U.S. sales generated $45.6 million in 2025, marking a strong start in a key market.

  • Resolution of Material Weakness in Internal Controls

    Management concluded that internal control over financial reporting was effective as of December 31, 2025, resolving a previously identified material weakness.

  • CFO Transition Announced

    Raj Denhoy will transition from CFO to SVP, Global Strategy, and Cassandra 'Sandra' Harris has been appointed as the new SVP and Chief Financial Officer, effective March 9, 2026.


Analysis · ESTA · Industrial Applications And Services

Establishment Labs' 2025 annual report reveals robust financial performance, with a 27.2% increase in revenue and a significant reduction in net loss, primarily driven by successful entry into the U.S. market. The resolution of a material weakness in internal controls over financial reporting is a notable positive, enhancing investor confidence in the company's financial integrity. However, the disclosure of a former CEO's plan to sell a substantial number of shares and the non-renewal notice from a sole-source silicone supplier introduce significant risks and potential headwinds. Investors should weigh the strong operational momentum and improved governance against these material insider activity and supply chain uncertainties.

At the time of this filing, ESTA was trading at $78.70 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $26.56 to $83.31. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ESTA - Latest Insights

ESTA
Jun 29, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $89.99
Real-time Price: $92.19 info
Change: +$2.20 (+2%) info
Market Cap: $2.717B info
ESTA
May 08, 2026, 4:08 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $71.77
Real-time Price: $92.19 info
Change: +$20.42 (+28%) info
Market Cap: $2.717B info
ESTA
May 06, 2026, 8:08 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $73.00
Real-time Price: $92.19 info
Change: +$19.19 (+26%) info
Market Cap: $2.717B info
ESTA
Apr 30, 2026, 3:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $68.21
Real-time Price: $92.19 info
Change: +$23.98 (+35%) info
Market Cap: $2.717B info
ESTA
Apr 30, 2026, 2:51 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $68.56
Real-time Price: $92.19 info
Change: +$23.63 (+34%) info
Market Cap: $2.717B info